Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-15-079510
Filing Date
2015-11-17
Accepted
2015-11-17 08:36:15
Documents
3
Period of Report
2015-11-17

Document Format Files

Seq Description Document Type Size
1 6-K a15-22780_26k.htm 6-K 20762
2 EX-99.1 a15-22780_2ex99d1.htm EX-99.1 411838
3 GRAPHIC g227802mm01i001.jpg GRAPHIC 1988
  Complete submission text file 0001104659-15-079510.txt   436443
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-15024 | Film No.: 151237092
SIC: 2834 Pharmaceutical Preparations